ESYT2, also known as FAM62B, is an extended synaptotagmin-like protein that plays a critical role in membrane contact sites between the endoplasmic reticulum (ER) and plasma membrane (PM). These ER-PM contact sites are essential for various cellular processes including lipid transfer, calcium signaling, and cell adhesion. Research has implicated ESYT2 in extracellular signal transduction and cell adhesion functions . The protein is encoded on chromosome 12 and is part of a family of proteins that includes ESYT1 and ESYT3, which have tissue-specific expression patterns . ESYT2's membrane localization makes it particularly valuable for studying ER-PM interactions in different cell types and under various physiological conditions.
The ESYT2/FAM62B Polyclonal Antibody with FITC conjugation is typically derived from rabbit hosts using KLH-conjugated synthetic peptides from human ESYT2/FAM62B protein (immunogen range: 801-921/921) . The antibody has the following specifications:
| Specification | Details |
|---|---|
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Conjugation | FITC (Fluorescein Isothiocyanate) |
| Concentration | 1ug/ul |
| Purification Method | Protein A |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol |
| Storage Condition | Store at -20°C with aliquoting recommended to avoid freeze-thaw cycles |
| Predicted Reactivity | Human, Mouse, Rat, Cow, Sheep, Pig, Horse, Chicken |
FITC-conjugated antibodies are sensitive to light exposure, which gradually diminishes fluorescence intensity .
The conjugation process may slightly affect the antibody's binding affinity compared to unconjugated versions.
FITC has an excitation maximum at approximately 495 nm and emission maximum at approximately 520 nm, requiring appropriate filter sets for visualization.
Direct conjugation eliminates potential cross-reactivity issues associated with secondary antibodies, particularly important in multi-labeling experiments.
The ESYT2/FAM62B polyclonal antibody with FITC conjugation has been validated for multiple experimental applications :
Western Blotting (WB) - For detecting ESYT2 protein in cell and tissue lysates
Immunofluorescence on paraffin-embedded tissues (IF/IHC-P) - For localizing ESYT2 in fixed tissue sections
Immunofluorescence on frozen tissue sections (IF/IHC-F) - For detecting ESYT2 in cryopreserved samples
Immunocytochemistry (ICC) - For visualizing ESYT2 localization in cultured cells
These applications leverage the antibody's specificity for ESYT2/FAM62B and the direct visualization capabilities provided by the FITC conjugation.
For optimal results with immunofluorescence using FITC-conjugated ESYT2 antibody, follow this methodological approach based on standard protocols for FITC-conjugated antibodies :
Sample Preparation:
Seed cells on appropriate coverslips or glass-bottomed plates
For tissue sections, prepare paraffin-embedded or frozen sections as needed
Fixation and Permeabilization:
Fix cells using 4% paraformaldehyde in PBS for 10 minutes at room temperature
Wash thoroughly with PBS
Permeabilize with 0.1% Triton X-100 for 10 minutes
Wash again with PBS
Blocking:
Incubate with blocking buffer (10% FBS, 1% BSA, 0.1% Triton X-100, and 0.01% NaN₃ in PBS) for 1 hour at room temperature
Antibody Incubation:
Dilute the FITC-conjugated ESYT2 antibody (recommended starting dilution 1:500) in blocking buffer
Incubate overnight at 4°C in a humidity chamber protected from light
Wash thoroughly with PBS (3-5 times, 5 minutes each)
Counterstaining (optional):
Counterstain nuclei with DAPI if desired
For multi-labeling experiments, use antibodies with compatible fluorophores
Mounting and Imaging:
Optimizing antibody dilution is crucial for balancing specific signal and background. For FITC-conjugated ESYT2 antibody:
Initial Titration Series:
Sample-Specific Considerations:
Application-Specific Optimization:
Western blotting may require different dilutions than immunofluorescence
TIRF microscopy focusing on membrane contacts may benefit from higher antibody concentrations than wide-field imaging
Always include positive and negative controls when optimizing dilutions
ESYT2 is involved in establishing and maintaining ER-PM contact sites, which has significant implications for experimental design :
Membrane Contact Site Gradients:
Recent research has demonstrated that ER-PM contacts form gradients within cells
These gradients appear to direct key cellular processes
When studying ESYT2, researchers should consider its distribution across these gradients rather than simple presence/absence in subcellular fractions
Visualization Techniques:
Total internal reflection fluorescence (TIRF) microscopy is particularly valuable for visualizing ESYT2 at ER-PM contact sites
This technique captures signals from the evanescent field, which extends only 100-200 nm from the coverslip surface
Using TIRF with FITC-conjugated ESYT2 antibody enables high-contrast imaging of membrane contact sites
Co-localization Studies:
ESYT2 expression varies significantly across tissues, which has important implications for experimental design :
Tissue Expression Profile:
ESYT2 mRNA is predominantly detected in lung, spleen, testis, and stomach
Lower expression levels are found in other tissues
This expression pattern overlaps significantly with ESYT1, except in testis
Experimental Implications:
Knockout Studies Interpretation:
For rigorous scientific validation, include these controls when working with FITC-conjugated ESYT2 antibody:
Positive Controls:
Negative Controls:
ESYT2 knockout or knockdown samples
Isotype control antibodies (rabbit IgG-FITC) to assess non-specific binding
Secondary antibody-only controls (for comparison with non-conjugated primary antibodies)
Specificity Controls:
Pre-absorption with immunizing peptide to confirm binding specificity
Western blot validation to confirm molecular weight of detected protein
Multiple antibodies targeting different epitopes of ESYT2 to confirm localization patterns
FITC is particularly susceptible to photobleaching, which can limit experimental duration and quantitative analysis . To address this:
Preventative Measures:
Minimize light exposure during all sample preparation steps
Use anti-fade mounting media containing anti-photobleaching agents
Store slides and samples in the dark at 4°C
Consider working under reduced ambient lighting conditions
Imaging Strategies:
Use neutral density filters to reduce excitation intensity
Minimize exposure times and interval durations for time-lapse imaging
Capture FITC channel images first in multi-channel acquisition sequences
Consider deconvolution strategies to enhance signal from lower exposure images
Alternative Approaches:
For long-term imaging or quantitative applications, consider antibodies conjugated to more photostable fluorophores (Alexa Fluor 488)
For fixed samples requiring archiving, document images promptly after preparation
High background can compromise signal-to-noise ratio in immunofluorescence experiments. Common causes and solutions include:
Inadequate Blocking:
Extend blocking time to 2 hours or overnight at 4°C
Increase blocking agent concentration (try 15-20% FBS or 2-5% BSA)
Add 0.1-0.3M glycine to blocking buffer to reduce aldehyde-induced autofluorescence
Non-specific Binding:
Increase antibody dilution (try 1:1000 or 1:2000)
Add 0.1-0.5% non-ionic detergent (Tween-20) to washing buffers
Pre-absorb antibody with acetone powder from non-target tissues
Autofluorescence:
Treat samples with 0.1-1% sodium borohydride after fixation to reduce autofluorescence
Include 10mM cupric sulfate in 50mM ammonium acetate (pH 5.0) treatment
Use spectral unmixing during image acquisition or processing
Fixation Issues:
Optimize fixation time (over-fixation can increase background)
Try alternative fixatives (methanol instead of paraformaldehyde)
Ensure complete permeabilization for intracellular epitopes
ESYT2 localization requires careful interpretation based on its known roles at ER-PM contact sites :
Expected Localization Patterns:
Interpretation Approaches:
Use co-localization with established markers (SEC61β for ER, CAAX for PM)
Compare distribution under normal conditions versus after calcium elevation (which may affect ESYT2 recruitment)
Consider three-dimensional distribution using z-stack imaging
Quantify intensity distributions relative to cell landmarks or gradients
Comparative Analysis:
Compare ESYT2 patterns with related proteins ESYT1 and ESYT3
Consider cell type-specific differences in localization patterns
Analyze changes in localization under different physiological or stress conditions
For robust quantitative analysis of ESYT2 at ER-PM contact sites:
Contact Site Quantification:
Measure density of ESYT2-positive puncta per unit membrane length
Calculate percentage of cell periphery containing ESYT2-positive contacts
Measure intensity profiles perpendicular to the plasma membrane to assess depth of contacts
Gradient Analysis:
Co-localization Analysis:
Calculate Pearson's or Manders' correlation coefficients with ER and PM markers
Use object-based colocalization to identify bona fide contact sites
Apply super-resolution techniques (STORM, STED) for nanometer-scale analysis